Cargando…
The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function
Despite the extraordinary success of HIV-1 antiretroviral therapy in prolonging life, infected individuals face lifelong therapy because of a reservoir of latently-infected cells that harbor replication competent virus. Recently, compounds have been identified that can reverse HIV-1 latency in vivo....
Autores principales: | Clutton, G., Xu, Y., Baldoni, P. L., Mollan, K. R., Kirchherr, J., Newhard, W., Cox, Kara, Kuruc, J. D., Kashuba, A., Barnard, R., Archin, N., Gay, C. L., Hudgens, M. G., Margolis, D. M., Goonetilleke, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969750/ https://www.ncbi.nlm.nih.gov/pubmed/27480951 http://dx.doi.org/10.1038/srep30749 |
Ejemplares similares
-
Corrigendum: The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function
por: Clutton, G., et al.
Publicado: (2016) -
HIV-Specific T Cell Responses Are Highly Stable on Antiretroviral Therapy
por: Xu, Yinyan, et al.
Publicado: (2019) -
A Reproducible, Objective Method Using MitoTracker® Fluorescent Dyes to Assess Mitochondrial Mass in T Cells by Flow Cytometry
por: Clutton, Genevieve, et al.
Publicado: (2018) -
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
por: Archin, NM, et al.
Publicado: (2012) -
Reliable Estimation of CD8 T Cell Inhibition of In Vitro HIV-1 Replication
por: Xu, Yinyan, et al.
Publicado: (2021)